Allspring Global Investments’s Cardiovascular Systems, Inc. CSII Stock Holding History

Allspring Global Investments’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,158	Closed	-$23K	–	2922
2023 Q1	$23K	Sell	1,158 -80,951	-99%	-$1.4M	﹤0.01%	2476
2022 Q4	$1.12M	Buy	82,109 +2,016	+3%	+$28.1K	﹤0.01%	1403
2022 Q3	$1.11M	Buy	80,093 +1,500	+2%	+$22.3K	﹤0.01%	1409
2022 Q2	$1.13M	Sell	78,593 -11,024	-12%	-$191K	﹤0.01%	1395
2022 Q1	$2.02M	Buy	89,617 +77,093	+616%	+$1.5M	﹤0.01%	1491
2021 Q4	$235K	Buy	+12,524	New	+$334K	﹤0.01%	2591

Other funds holding CSII

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Allspring Global Investments's CSII Position: Q2 2023 in Review

Allspring Global Investments sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 1,158 shares — an estimated $23K sold.

Allspring Global Investments first reported a position in CSII in Q4 2021 and held it in 6 quarters. The position peaked at $2.02M in Q1 2022. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Allspring Global Investments reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Allspring Global Investments sold 1,158 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $23K.
Allspring Global Investments first reported a position in Cardiovascular Systems, Inc. in Q4 2021 and held it in 6 quarters.
Allspring Global Investments's Cardiovascular Systems, Inc. position peaked at $2.02M in Q1 2022.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.